Atrys Health SL (ATRY) - Total Assets
Based on the latest financial reports, Atrys Health SL (ATRY) holds total assets worth €579.13 Million EUR (≈ $677.07 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Atrys Health SL for net asset value and shareholders' equity analysis.
Atrys Health SL - Total Assets Trend (2012–2024)
This chart illustrates how Atrys Health SL's total assets have evolved over time, based on quarterly financial data.
Atrys Health SL - Asset Composition Analysis
Current Asset Composition (December 2024)
Atrys Health SL's total assets of €579.13 Million consist of 15.3% current assets and 84.7% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 3.5% |
| Accounts Receivable | €52.82 Million | 9.0% |
| Inventory | €1.57 Million | 0.3% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €156.74 Million | 26.8% |
| Goodwill | €267.35 Million | 45.8% |
Asset Composition Trend (2012–2024)
This chart illustrates how Atrys Health SL's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Atrys Health SL.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Atrys Health SL's current assets represent 15.3% of total assets in 2024, a decrease from 26.0% in 2012.
- Cash Position: Cash and equivalents constituted 3.5% of total assets in 2024, up from 2.5% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 71.0% of total assets, an increase from 40.0% in 2012.
- Asset Diversification: The largest asset category is goodwill at 45.8% of total assets.
Atrys Health SL Competitors by Total Assets
Key competitors of Atrys Health SL based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Royalty Pharma Plc
NASDAQ:RPRX
|
USA | $19.62 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578
|
China | CN¥7.26 Billion |
|
Hebei Changshan Biochem Pharma
SHE:300255
|
China | CN¥4.66 Billion |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252
|
China | CN¥38.02 Billion |
|
Shanghai Junshi Biosciences Co Ltd
SHG:688180
|
China | CN¥11.69 Billion |
|
Spyre Therapeutics Inc.
NASDAQ:SYRE
|
USA | $504.60 Million |
|
Soleno Therapeutics Inc
NASDAQ:SLNO
|
USA | $563.83 Million |
Atrys Health SL - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.83 | 0.98 | 1.74 |
| Quick Ratio | 0.81 | 0.96 | 1.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-19.31 Million | €-2.01 Million | €15.85 Million |
Atrys Health SL - Advanced Valuation Insights
This section examines the relationship between Atrys Health SL's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.89 |
| Latest Market Cap to Assets Ratio | 0.37 |
| Asset Growth Rate (YoY) | -7.1% |
| Total Assets | €584.19 Million |
| Market Capitalization | $214.84 Million USD |
Valuation Analysis
Below Book Valuation: The market values Atrys Health SL's assets below their book value (0.37x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Atrys Health SL's assets decreased by 7.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Atrys Health SL (2012–2024)
The table below shows the annual total assets of Atrys Health SL from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €584.19 Million ≈ $682.98 Million |
-7.12% |
| 2023-12-31 | €629.00 Million ≈ $735.37 Million |
-10.82% |
| 2022-12-31 | €705.28 Million ≈ $824.55 Million |
+24.69% |
| 2021-12-31 | €565.63 Million ≈ $661.28 Million |
+221.79% |
| 2020-12-31 | €175.78 Million ≈ $205.50 Million |
+99.65% |
| 2019-12-31 | €88.04 Million ≈ $102.93 Million |
+63.97% |
| 2018-12-31 | €53.69 Million ≈ $62.77 Million |
+33.58% |
| 2017-12-31 | €40.20 Million ≈ $46.99 Million |
+31.50% |
| 2016-12-31 | €30.57 Million ≈ $35.74 Million |
+17.14% |
| 2015-12-31 | €26.10 Million ≈ $30.51 Million |
+33.62% |
| 2014-12-31 | €19.53 Million ≈ $22.83 Million |
+3.49% |
| 2013-12-31 | €18.87 Million ≈ $22.06 Million |
+3.16% |
| 2012-12-31 | €18.29 Million ≈ $21.39 Million |
-- |
About Atrys Health SL
Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of r… Read more